drugset / Trial / NCT01413958

Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)

NCT01413958

Phase 3 Completed 575 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare the nasal congestion symptom relief of phenylephrine extended release tablets and placebo in participants with allergic rhinitis.

Timeline

Start
2011-08
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenylephrine Small molecule 30 mg Oral
Background Loratadine Small molecule 10 mg